Reik Loser

Dresden, SN 01069, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications

Development of Cathepsin B‑Activatable Cell-Penetrating Peptides for Tumor Targeting.

Development of Cathepsin B‑Activatable Cell-Penetrating Peptides for Tumor Targeting.

Journal: ACS pharmacology & translational science
Published: November 14, 2025

"Precision on Two Wheels"─Structural Refinement of 64Cu- and 68Ga-Labeled Bicyclic Peptides Targeting Nectin-4 for Improved Tumor Imaging: From Preclinical Development to First-in-Human Application.

"Precision on Two Wheels"─Structural Refinement of 64Cu- and 68Ga-Labeled Bicyclic Peptides Targeting Nectin-4 for Improved Tumor Imaging: From Preclinical Development to First-in-Human Application.

Journal: Journal of medicinal chemistry
Published: October 13, 2025

Deciphering the Tumor Uptake of Heterobivalent (SST2/Albumin) [64Cu]Cu-NODAGA-cLAB-TATEs.

Deciphering the Tumor Uptake of Heterobivalent (SST2/Albumin) [64Cu]Cu-NODAGA-cLAB-TATEs.

Journal: Journal of medicinal chemistry
Published: May 20, 2025

Preclinical evaluation of an 18F-labeled Nε-acryloyllysine piperazide for covalent targeting of transglutaminase 2.

Preclinical evaluation of an 18F-labeled Nε-acryloyllysine piperazide for covalent targeting of transglutaminase 2.

Journal: EJNMMI radiopharmacy and chemistry
Published: November 06, 2023

Lysyl Oxidases as Targets for Cancer Therapy and Diagnostic Imaging.

Lysyl Oxidases as Targets for Cancer Therapy and Diagnostic Imaging.

Journal: ChemMedChem
Published: June 28, 2023

Dipeptide-Derived Alkynes as Potent and Selective Irreversible Inhibitors of Cysteine Cathepsins.

Dipeptide-Derived Alkynes as Potent and Selective Irreversible Inhibitors of Cysteine Cathepsins.

Journal: Journal of medicinal chemistry
Published: March 03, 2023

Enzymological Characterization of 64Cu-Labeled Neprilysin Substrates and Their Application for Modulating the Renal Clearance of Targeted Radiopharmaceuticals.

Enzymological Characterization of 64Cu-Labeled Neprilysin Substrates and Their Application for Modulating the Renal Clearance of Targeted Radiopharmaceuticals.

Journal: Journal of medicinal chemistry
Published: January 03, 2023

The Impact of Nε-Acryloyllysine Piperazides on the Conformational Dynamics of Transglutaminase 2.

The Impact of Nε-Acryloyllysine Piperazides on the Conformational Dynamics of Transglutaminase 2.

Journal: International journal of molecular sciences
Published: December 20, 2022

Author Correction: Sulfated glycosaminoglycans inhibit transglutaminase 2 by stabilizing its closed conformation.

Author Correction: Sulfated glycosaminoglycans inhibit transglutaminase 2 by stabilizing its closed conformation.

Journal: Scientific reports
Published: September 28, 2022

Sulfated glycosaminoglycans inhibit transglutaminase 2 by stabilizing its closed conformation.

Sulfated glycosaminoglycans inhibit transglutaminase 2 by stabilizing its closed conformation.

Journal: Scientific reports
Published: April 13, 2022

The Role of Transglutaminase 2 in the Radioresistance of Melanoma Cells.

The Role of Transglutaminase 2 in the Radioresistance of Melanoma Cells.

Journal: Cells
Published: March 31, 2022

Application of a Fluorescence Anisotropy-Based Assay to Quantify Transglutaminase 2 Activity in Cell Lysates.

Application of a Fluorescence Anisotropy-Based Assay to Quantify Transglutaminase 2 Activity in Cell Lysates.

Journal: International journal of molecular sciences
Published: March 22, 2022
Showing 1-12 of 41

Last Updated: 09/26/2026